Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Deloitte
Teva
Colorcon
Citi
Baxter
Farmers Insurance
Daiichi Sankyo
Julphar

Generated: June 24, 2018

DrugPatentWatch Database Preview

VESPRIN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Vesprin, and when can generic versions of Vesprin launch?

Vesprin is a drug marketed by Apothecon and Bristol Myers Squibb and is included in three NDAs.

The generic ingredient in VESPRIN is triflupromazine. There are two drug master file entries for this compound. Additional details are available on the triflupromazine profile page.
Summary for VESPRIN
Drug patent expirations by year for VESPRIN
Medical Subject Heading (MeSH) Categories for VESPRIN
Synonyms for VESPRIN
10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine
10-[3-(Dimethylamino)propyl]-2-(trifluoromethyl)phenothiazine
10-3-(Dimethylamino)propyl-2-(trifluoromethyl)phenothiazine
10H-Phenothiazine-10-propanamine, N,N-dimethyl-2-(trifluoromethyl)-
146-54-3
146T543
2-(Trifluoromethyl)promazine
2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine
3B1-001409
AB00053647
AB00053647_16
AB00053647_17
AC1L1KMZ
AC1Q4JZU
Adazine
API0009159
BDBM67544
BPBio1_000227
BSPBio_000205
BSPBio_003444
C18H19F3N2S
CAS-1098-60-8
CCG-205220
CHEBI:9711
CHEMBL570
cid_66069
D00390
D05NOS
DB00508
dimethyl-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]amine;hydrochloride
dimethyl({3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl})amine
DivK1c_000808
DTXSID9023704
EINECS 205-673-6
Fluopromazine
Fluopromazine monohydrochloride
GTPL4330
HSDB 3407
IDI1_000808
KBio1_000808
KBio2_000515
KBio2_003083
KBio2_005651
KBioGR_001062
KBioSS_000515
L001149
Lopac-T-2896
Lopac0_001146
LS-105500
MCULE-9151902507
N,N-Dimethyl-2-(trifluoromethyl)-10H-phenothiazine-10-propanamine
N,N-dimethyl-3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)-1-propanamine
N,N-dimethyl-3-[2-(trifluoromethyl)-10-phenothiazinyl]-1-propanamine;hydrochloride
N,N-Dimethyl-3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]-1-propanamine #
N,N-dimethyl-3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propan-1-amine
N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan
N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine
N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine hydrochloride
N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine;hydrochloride
NCGC00016012-01
NCGC00016012-02
NCGC00016012-03
NCGC00016012-04
NCGC00016012-05
NCGC00016012-06
NCGC00016012-07
NCGC00016012-08
NCGC00016012-09
NCGC00024300-04
NCI60_001029
NCI60_001426
NINDS_000808
NSC14959
NSC17473
PDSP1_001344
PDSP2_001328
Phenothiazine, 10-(3-(dimethylamino)propyl)-2-(trifluoromethyl)-
Phenothiazine, 10-[3-(dimethylamino)propyl]-2-(trifluoromethyl)-
PL006907
PL046383
Prestwick0_000053
Prestwick1_000053
Prestwick2_000053
Prestwick3_000053
Psyquil
RO16TQF95Y
SBI-0051113.P003
SCHEMBL44085
Siquil
SPBio_002126
Spectrum_000095
Spectrum4_000741
Spectrum5_001282
SR-01000000224-4
Trifluopromazine
Trifluopromazine hydrochloride
Triflupromazin
Triflupromazina
Triflupromazina [INN-Spanish]
triflupromazine
Triflupromazine (USP/INN)
Triflupromazine [INN]
Triflupromazine [USP:INN:BAN]
Triflupromazine HCl
Triflupromazinum
Triflupromazinum [INN-Latin]
UNII-RO16TQF95Y
Vesprin (TN)
Vetame
XSCGXQMFQXDFCW-UHFFFAOYSA-N
ZINC538507

US Patents and Regulatory Information for VESPRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon VESPRIN triflupromazine hydrochloride INJECTABLE;INJECTION 011325-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb VESPRIN triflupromazine hydrochloride TABLET;ORAL 011123-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apothecon VESPRIN triflupromazine SUSPENSION;ORAL 011491-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apothecon VESPRIN triflupromazine hydrochloride INJECTABLE;INJECTION 011325-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cantor Fitzgerald
Express Scripts
Argus Health
Queensland Health
Farmers Insurance
QuintilesIMS
Cerilliant
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.